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Envelope glycoprotein E2 (gp51 to gp54) is the major neutralizing antigen of pestiviruses, which include classical swine
fever virus (CSFV), bovine viral diarrhoea virus (BVDV), and border disease virus (BVD). Previous studies carried out using
a panel of monoclonal antibodies raised against CSFV strain Brescia have revealed the existence of four antigenic domains,
A to D, of the E2 protein, all of which are located at the N-terminal half of the molecule. Here we report the detailed
mapping, using three complementary techniques, of a novel linear epitope located at the C-terminal part of the molecule,
which reacted with a monoclonal antibody (4-9D4) as well as polyclonal animal sera. This epitope is highly conserved in
the three different members of pestiviruses and hence can be used as a genus-specific diagnosis tool. The observation
that this epitope is not accessible on the native virus surface, together with its C-terminal location, supports a recently
proposed structural model, indicating that the C-terminal part of E2 is membrane-bound while the N-terminal half of the
molecule is exposed on the virus surface. q 1996 Academic Press, Inc.
The genus Pestivirus of the Flaviridae family is com- candidate for recombinant vaccine development as well
posed of three members, i.e., classical swine fever virus as for serum diagnosis.
(CSFV), bovine viral diarrhoea virus (BVDV), and border Using mAbs directed against the E2 protein of CSFV
disease virus (BDV) (1). Pestiviruses are structurally and strain Brescia, four antigenic domains, A to D, have been
antigenically closely related. Antibodies derived from ani- identified on the E2 protein (15–18). All of them are lo-
mals infected with one group of viruses often cross-react cated in the N-terminal half of the molecule between
with the other members of the genus (2). However, most amino acid residues 690 and 866. The N-terminal half of
monoclonal antibodies (mAb) directed against structural the molecule has been shown to be important for virus
proteins are able to discriminate between CSFV and neutralization (15, 18). From their epitope mapping data,
BVDV (3–5). Van Rijn et al. (18) have recently proposed a structural
The genome of pestiviruses is a positive-stranded RNA model for the E2 protein, which provides the location of
of about 12.5 kb (6 – 8). The genome codes for a single the four antigenic domains, the potential glycosylation
open reading frame (ORF) flanked by two short noncod- sites, and the important disulfide bonds. In this model,
ing regions. The open reading frame is translated into a the C-terminal 35 amino acid residues are buried in the
polyprotein of approximately 4000 amino acids in length, membrane envelope.
which is then processed into individual polypeptides by In this paper we report the identification and detailed
virus- and cell-encoded proteases (9). It has been sug- mapping of a linear epitope located at the C-terminal
gested that the nomenclature for pestivirus glycoproteins part of the E2 protein. This represents a new antigenic
to change from molecular mass-based names (e.g., gp53) region of the E2 protein which has not been reported
to position-based names (e.g., E2) (9). The coding regions before. Our epitope mapping results are consistent and
for the three envelope glycoproteins E0 (gp44–48), E1 complementary to the previous data which led to the
(gp31–33), and E2 (gp51–54) have been mapped for proposal of the above mentioned structural model of E2.
CSFV (8–10). The major envelope glycoprotein E2 is lo-
The mAb 4-9D4 used in this study was raised in micecated between amino acid residues 690 and 1060 of the
against a denatured recombinant E2 protein producedsingle ORF polyprotein (7, 11). Among the three envelope
in yeast using an cDNA clone coding for amino acidglycoproteins, E2 is the most antigenic, and an immune
residues 544–1093 of E2 protein from CSFV strain Wey-response against E2 alone is sufficient for protection
bridge (19; also M. Yu and J. White, unpublished results).(12–14). Therefore, E2 has long been considered an ideal
Initial characterization of the mAb indicated that it recog-
nized a linear epitope of the E2 protein, which is not
accessible in the native virus. In Western blot, mAb 4-1 To whom reprint requests should be addressed.
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a 21-aa peptide (KNKYYEPRDSYFQQYMLKGEY) which
corresponds to amino acid residues 991–1012 of the
CSFV E2 protein (7, 19). The 8th clone contained a larger
insert corresponding to amino acid residues 985–1051,
which covered the smaller 21-aa insert sequence iso-
lated in the other 7 clones. Further analysis was, there-
fore, concentrated on the clone containing the 21-aa in-
sert, which was named f1CSFV-D4. Recombinant phage
particles were purified from f1CSFV-D4 by three times
PEG precipitation and tested for their reactivity with poly-
clonal animal sera. Positive results were obtained, in
ELISA and Western blot, with polyclonal sera raised
FIG. 1. Western blot analysis of pestivirus E2 proteins using mAb 4- against CSFV and/or BVDV in pig and goat (data not
9D4. Preparation of viral antigens were carried out using standard shown).
methods. Cell pellets, both infected or noninfected, were treated with
Second, mAb 4-9D4 was also used to select for mAb-NP-40 to release viruses. Western blot was carried out as described
specific peptides from a synthetic peptide phage displayin (20). Lane 1, PK15 cell lysate, used as a negative control; Lanes 2
and 3, CSFV strains NSW and Baker, respectively; Lane 4, Lamb testis library obtained from G. Smith (S. Choukri and G. Smith,
(LT) cell lysate, used as negative control; Lanes 5–7, BVDV strains unpublished results). This library was constructed by in-
NADL, Singer, and Osloss, respectively; Lane 8, BDV strain BD78. The serting random oligonucleotide fragments, coding for
numbers given at the left are molecular weight standards determined
random 15-mer peptides, into the gene VIII display vectorfrom the prestained molecular weight markers obtained from Bio-Rad.
f88-4 (23). After two rounds of affinity selection as de-
scribed (20, 22), positive clones were picked up by a
colony blotting procedure (24), followed by confirmation9D4 not only reacted with the recombinant E2 protein
originally used for immunization (data not shown), but with ELISA analysis. Twelve positive clones were then
selected for further analysis by sequencing. As shownalso reacted with viral E2 proteins derived from all pesti-
virus strains available for testing in our laboratory (see in Fig. 2A, these clones represent 10 different classes of
inserts, all of them contained a 4-amino acid residueFig. 1). The mAb failed to react in ELISA with purified
native virus particles (C. Morrissy, unpublished results). core consensus region, highly homologous to the YYEP
sequence in the E2 protein of CSFV. These results notHowever, positive ELISA results could be obtained after
the purified virions were first treated with 1% NP-40 for only corroborated the data obtained above from the E2-
targeted phage display epitope library, but also revealed2 hr at room temperature. When cell monolayer was
treated with 2–3% formalin and 0.1% NP-40, positive re- that YYEP is the critical binding site for 4-9D4. It is inter-
esting to note that there was not much sequence homol-sults were also obtained in immunoperoxidase test (C.
Morrisy, unpublished results). These results suggest that ogy in the flanking regions of the 15-mer inserts, sug-
gesting that the YYEP tetra-peptide is sufficient for mAbthe 4-9D4 epitope is not accessible on the surface of the
native virions. 4-9D4 recognition. The results also indicated that among
the YYEP tera-peptide sequence, the second positionTo map the epitope defined by mAb 4-9D4, three com-
plementary mapping techniques were employed. These (occupied by Y) allows limited sequence variation (see
more discussion below).include the use of two different types of phage display
epitope libraries followed by the application of overlap- Sequence alignment, in Fig. 2B, for the YYEP-region
from E2 proteins of all pestiviruses whose E2 gene hasping synthetic peptides in competition ELISA analysis.
First, a gene-targeted phage display epitope library been sequenced indicated a strong sequence conserva-
tion in this region. This provides molecular evidence forwas constructed using the procedures previously devel-
oped by our group (20, 21). Briefly, using the 1.7-kb cDNA our initial finding that mAb 4-9D4 was able to react with
E2 proteins from all the pestiviruses available for testingof CSFV E2 cloned in pUC vector (19) as starting material,
DNase I partial digestion was conducted to enrich for in our laboratory (Fig. 1). Furthermore, the only sequence
variation in this region, i.e., the replacement of the Yrandom fragments in the range of 100–200 bp. After end-
repairing, the blunt-ended small fragments were inserted residue in CSFV strains, at the second position of the
YYEP tetra-peptide, by the F residue in some BVDVinto the phage display vector fUSE1 (22), which was cut
with PvuII and dephosphorylated with calf intestine alka- strains is in support of the finding obtained from the
studies of random phage-displayed peptides as shownline phosphatase, to obtain a random epitope library con-
taining approximately 51 105 independent phage clones. in Fig. 2A.
In parallel, a third approach, utilizing a multipin peptideAfter two rounds of affinity selection using mAb 4-9D4, 8
positive clones were selected which displayed peptides synthesis system (25), was also used. Briefly, overlapping
8-mer peptides, offset by one, spanning residues 989–reactive with 4-9D4 in both ELISA and Western blot (data
not shown). DNA sequencing analysis indicated that 7 1012 of CSFV E2 protein were synthesized on polyethyl-
ene pins with a linker allowing cleavage of the peptidesof the 8 clones contained an identical insert coding for
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(numbers 2–6), which had significant binding to mAb 4-
9D4, all shared the common sequence of YYEP. The C-
ELISA analysis was carried out essentially as described
in (27). Briefly, mAb 4-9D4 (1:100) was first incubated
with individual peptides at 377 for 2 hr, spun for 10 min
to remove any precipitated antigen/antibody complexes,
then added to antigen-coated plates and incubated at
377 for 1 hr. Bound antibodies were detected as in I-
ELISA. Again, only peptides 2–6 demonstrated strong
competition (Fig. 3B). These results not only indicated
that the core tetra-peptide YYEP constitutes the discrete
antibody binding site from mAb 4-9D4, but also demon-
strated that mAb 4-9D4 could bind to YYEP-containing
peptides either displayed on phage surface or in free
solution. It is interesting to note that among the five posi-
tive peptides number 3 had the weakest binding in both
I- and C-ELISA analyses. This might be due to its high
content of positively charged residues (KNKYYEPR, 3/,
10), since the two flanking peptides carried less positive
charge (peptide 2: 2/, 10; peptide 4: 2/, 20) and bind
the mAb much better than peptide 3.
In summary, our data demonstrated that efficient and
high resolution epitope mapping can be achieved using
phage display technology. The complementary use of
both gene-targeted epitope library and synthetic peptide
FIG. 2. Sequence analysis of the 4-9D4 epitope. (A) Alignment of
peptide sequences isolated from synthetic peptide phage display li-
brary. The top sequence (f1CSFV-D4) is the epitope fragment isolated
from the E2-targeted phage display library, which corresponds to amino
acid residues 991–1012 of the CSFV E2 protein (7, 19). The 10 different
15-mer sequences derived from the random synthetic peptide library
were given at the lower part of the figure, aligning the YYEP core
consensus region. Identical amino acid residues to the top sequence
are indicated by dots. (B) Comparison of pestivirus E2 sequences
around the YYEP region. The amino acid sequences were obtained
from GenBank database (as given by their accession numbers): Wey-
bridge, X71780; Brescia, M31768; C, Z46758; GPE, D49533; LPC,
U35740; ALD, D49532; Alfort, J044358; Singer, L12455; SD-1, M96751;
Osloss, M96687; C24V, L07496; BD78, U18330. The NADL sequence
was taken from (5). Amino acid residues identical to the top Weybridge
sequence are indicated by dots.
(26). At the N-terminus of the peptide, a biotin tag and
the 4-residue spacer (Ser-Gly-Ser-Gly) were incorporated
while the C-terminus of the peptide was kept free. After
synthesis, the peptides were cleaved into a physiologi-
cally compatible buffer (0.166 M phosphate, pH 8.0) and
tested for their capacity to bind mAb 4-9D4 in both indi-
rect ELISA (I-ELISA) and competition ELISA (C-ELISA). In
the I-ELISA, the peptides (diluted 1:100 in PBST from a
1 mg/ml stock) were immobilized via the biotin tag onto
a streptavidin-coated plate by incubation at 377 for 1 hr.
The plate was then incubated with mAb 4-9D4 (1:50) at
FIG. 3. Peptide ELISA analysis. Same peptides were used for both377 for 1 hr and bound antibody detected by a 0.5 hr
I-ELISA (A) and C-ELISA (B) analysis with the sequence of each peptide
incubation with horse radish peroxidase-conjugated given at the bottom of B. Purified recombinant phage f1CSFV-D4 was
sheep anti-mouse antibodies (1:5000). The results shown used as ELISA antigen in the C-ELISA analysis. The readings given
were the average of two separate determinations.in Fig. 3A clearly demonstrated that the five peptides
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